We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$1.8B
AUM Growth
+$213M
Cap. Flow
+$72.2M
Cap. Flow %
4.02%
Top 10 Hldgs %
21.74%
Holding
131
New
18
Increased
54
Reduced
43
Closed
10

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$18.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$17.5M
4
LRCX icon
Lam Research
LRCX
+$17M
5
BOOT icon
Boot Barn
BOOT
+$16.9M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$15.5M
2
WM icon
Waste Management
WM
+$15.4M
3
OMCL icon
Omnicell
OMCL
+$14.1M
4
TRV icon
Travelers Companies
TRV
+$13.2M
5
WEX icon
WEX
WEX
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 20.28%
2 Financials 14.62%
3 Healthcare 13.69%
4 Communication Services 11.3%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCL icon
126
Royal Caribbean
RCL
$85.6B
-73,327
Closed -$7.94M
ULTA icon
127
Ulta Beauty
ULTA
$24.3B
-5,553
Closed -$1.39M
WM icon
128
Waste Management
WM
$91B
-134,062
Closed -$15.4M
TRHC
129
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-192,744
Closed -$10.6M
XLNX
130
DELISTED
Xilinx Inc
XLNX
-124,106
Closed -$11.9M
ETFC
131
DELISTED
E*Trade Financial Corporation
ETFC
-210,595
Closed -$9.2M

Similar funds

Braun Stacey Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Braun Stacey Associates held 131 positions worth $1.8B, up 13% from $1.58B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Braun Stacey Associates deployed $72.2M of net new capital in Q4 2019, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was CVS Health: 261,118 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Omnicell, an estimated $14.1M trimmed.

  • Braun Stacey Associates's largest Q4 2019 buy was CVS Health: 261,118 shares worth $19.4M.
  • Braun Stacey Associates added most to AT&T in Q4 2019, an estimated $8.22M increase.
  • Braun Stacey Associates's biggest Q4 2019 reduction was Omnicell, cutting an estimated $14.1M.
  • Braun Stacey Associates fully exited Cisco in Q4 2019, selling an estimated $15.5M.
  • Braun Stacey Associates's ten largest holdings make up 22% of its $1.8B portfolio in Q4 2019.
  • Braun Stacey Associates opened 18 new positions and closed 10 in Q4 2019.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $1.8B.

Based on Braun Stacey Associates's 13F filing for Q4 2019, filed 24 Jan 2020.